Bulletin
Investor Alert

New York Markets Open in:

Annovis Bio Inc.

NYS: ANVS

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

May 23, 2022, 4:41 p.m.

/zigman2/quotes/216213707/composite

$

8.98

Change

0.00 0.00%

Volume

Volume 169

Quotes are delayed by 20 min

/zigman2/quotes/216213707/composite

Previous close

$ 9.15

$ 8.98

Change

-0.17 -1.86%

Day low

Day high

$8.87

$9.20

Open

52 week low

52 week high

$8.39

$132.00

Open

Annual Financials for Annovis Bio Inc.

Operating Activities

Fiscal year is January-December. All values USD millions. 20172018201920202021 5-year trend
Net Income before Extraordinaries (682,349)(713,871)(990,980)(5.46M)(14.49M)
Depreciation, Depletion & Amortization -----
Depreciation and Depletion -----
Amortization of Intangible Assets -----
Deferred Taxes & Investment Tax Credit -----
Deferred Taxes -----
Investment Tax Credit -----
Other Funds 48,49582,72892,9121.89M4.7M
Funds from Operations (633,854)(631,143)(898,068)(3.57M)(9.79M)
Extraordinaries -----
Changes in Working Capital 96,37372,534421,526(400,714)657,346
Receivables --(735,075)735,075-
Accounts Payable 36,914(2,682)969,091(695,660)346,218
Other Assets/Liabilities (2,368)(5,189)5,101(34,097)(270,788)
Net Operating Cash Flow (537,481)(558,609)(476,542)(3.97M)(9.13M)

Investing Activities

20172018201920202021 5-year trend
Capital Expenditures -----
Capital Expenditures (Fixed Assets) -----
Capital Expenditures (Other Assets) -----
Net Assets from Acquisitions -----
Sale of Fixed Assets & Businesses -----
Purchase/Sale of Investments -----
Purchase of Investments -----
Sale/Maturity of Investments -----
Other Uses -----
Other Sources -----
Net Investing Cash Flow -----

Financing Activities

20172018201920202021 5-year trend
Cash Dividends Paid - Total -----
Common Dividends -----
Preferred Dividends -----
Change in Capital Stock 332,495246,449(78,611)9,21746.74M
Repurchase of Common & Preferred Stk. -----
Sale of Common & Preferred Stock 332,495246,449(78,611)9,21746.74M
Proceeds from Stock Options 332,495246,449(78,611)9,21746.65M
Other Proceeds from Sale of Stock ----95,102
Issuance/Reduction of Debt, Net --521,69912.03M-
Change in Current Debt -----
Change in Long-Term Debt --521,69912.03M-
Issuance of Long-Term Debt --521,69912.03M-
Reduction in Long-Term Debt -----
Other Funds -----
Other Uses -----
Other Sources -----
Net Financing Cash Flow 332,495246,449443,08812.04M46.74M
Exchange Rate Effect -----
Miscellaneous Funds -----
Net Change in Cash (204,986)(312,160)(33,454)8.07M37.61M
Free Cash Flow (537,480)(558,610)(476,540)(3.97M)(9.13M)
Link to MarketWatch's Slice.